RecruitingNot ApplicableNCT06870383

Erector Spinae Block Versus Combined Pecto-intercostal and Recto-intercostal Fascial Plane Block in Cardiac Surgery

Analgesic Efficacy of Erector Spinae Plane Block Versus Combined Pecto-intercostal and Recto-intercostal Fascial Plane Block in Patients Undergoing Cardiac Surgery: A Randomized Comparative Trial


Sponsor

Tanta University

Enrollment

66 participants

Start Date

Mar 20, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The aim of this study is to compare the analgesic effects of ultrasound-guided bilateral erector spinae plane block versus ultrasound-guided bilateral combined Pecto-intercostal fascial plane block and recto-intercostal fascial plane block in patients undergoing cardiac surgery.


Eligibility

Min Age: 21 YearsMax Age: 65 Years

Inclusion Criteria3

  • Age from 21 to 65 years.
  • Both sexes.
  • Scheduled for open heart surgery with cardiopulmonary bypass and midline sternotomy.

Exclusion Criteria5

  • History of chronic pain or Long-term or recent use of opioids.
  • History of allergy to local anesthetic drugs.
  • Ejection fraction of left ventricle less than 30%.
  • History of psychiatric diseases or any neurological disorders.
  • Pre-existing major organ dysfunction as hepatic or renal failure.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGErector spinae plane block

The block will be done under ultrasound guidance using 20 ml bupivacaine 0.25% that will be injected for each side ensuring not to exceed the maximal 2 mg/kg bupivacaine dose.

DRUGCombined Pecto-intercostal and recto-intercostal fascial plane block

The blocks will be done under ultrasound guidance using 10-15 ml of 0.25% bupivacaine that will be injected for each side ensuring not to exceed the maximal 2 mg/kg bupivacaine dose..


Locations(1)

Tanta University Hospitals

Tanta, Gharbia Governorate, Egypt

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06870383


Related Trials